The dataset connects claims, labs and EHR, including physician notes to analyse: Who meets drug label or payer criteria based on actual BMI and comorbidities How titration and dosing progress in real-world care What metabolic outcomes patients achieve over time Which safety signals, such as liver or renal changes, emerge across populations Why patients discontinue or switch treatments, as documented in notes See real-world GLP-1 evidence in action Register for our webinar where we dive deeper into GLP-1 real-world evidence
Visibly smoother, firmer-looking skin
Right now, the focus is largely on their role in managing diabetes and obesity, but the research is really starting to show some interesting possibilities for mood disorders
If you have a family history of medullary thyroid cancer, multiple endocrine neoplasias, or acute pancreatitis, it is advisable to avoid using GLP-1 drugs
(3) Zhang C, Xie Y, Chen H, Lv L, Yao J, Zhang M, Xia K, Feng X, Li Y, Liang X, Sun X, Deng C, Liu G
This dual peptide blend has become increasingly popular in research environments because it allows scientists to investigate complementary biological mechanisms using a single research product